172 related articles for article (PubMed ID: 20816832)
21. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial?
Mathioudakis AG; Amanetopoulou SG; Gialmanidis IP; Chatzimavridou-Grigoriadou V; Siasos G; Evangelopoulou E; Mathioudakis GA
Respirology; 2013 Jan; 18(1):147-53. PubMed ID: 22985270
[TBL] [Abstract][Full Text] [Related]
22. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
Telenga ED; Kerstjens HA; Postma DS; Ten Hacken NH; van den Berge M
Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
[TBL] [Abstract][Full Text] [Related]
23. [Inhaled corticosteroid/beta-2 agonist therapy in moderate COPD].
Yıldırım N
Tuberk Toraks; 2010; 58(2):192-201. PubMed ID: 20865575
[TBL] [Abstract][Full Text] [Related]
24. The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review.
Andreeva-Gateva PA; Stamenova E; Gatev T
Postgrad Med; 2016 Jun; 128(5):474-84. PubMed ID: 27153510
[TBL] [Abstract][Full Text] [Related]
25. Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender.
Tashkin DP; Varghese ST
Pulm Pharmacol Ther; 2011 Feb; 24(1):147-52. PubMed ID: 20659577
[TBL] [Abstract][Full Text] [Related]
26. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD?
Hamilton T; Miller JB; Vincent EC; St Anna L
J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909
[No Abstract] [Full Text] [Related]
27. Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.
Falk JA; Minai OA; Mosenifar Z
Proc Am Thorac Soc; 2008 May; 5(4):506-12. PubMed ID: 18453363
[TBL] [Abstract][Full Text] [Related]
28. Methodological issues in therapeutic trials of COPD.
Suissa S; Ernst P; Vandemheen KL; Aaron SD
Eur Respir J; 2008 May; 31(5):927-33. PubMed ID: 18216056
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
[TBL] [Abstract][Full Text] [Related]
30. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
Gagnon YM; Levy AR; Spencer MD; Hurley JS; Frost FJ; Mapel DW; Briggs AH
Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
[TBL] [Abstract][Full Text] [Related]
31. [Inhaled corticosteroids for COPD].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1398-404. PubMed ID: 12894463
[TBL] [Abstract][Full Text] [Related]
32. Initiating Low-Value Inhaled Corticosteroids in an Inception Cohort with Chronic Obstructive Pulmonary Disease.
Spece LJ; Donovan LM; Griffith MF; Keller T; Feemster LC; Smith NL; Au DH
Ann Am Thorac Soc; 2020 May; 17(5):589-595. PubMed ID: 31899652
[No Abstract] [Full Text] [Related]
33. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
Donohue JF; Ohar JA
Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
[TBL] [Abstract][Full Text] [Related]
34. Steroid therapy in chronic obstructive pulmonary disease.
OBrien A; Ward NS
Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
[TBL] [Abstract][Full Text] [Related]
35. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
36. [The effects of inhaled steroids withdrawal in COPD].
Jebrak G; Honore I; Serrier P; Dumoulin J; Terrioux P; Soyez F; Maurer C; Mangiapan G; Febvre M; Couderc LJ; Braun JM; Chinet T
Rev Mal Respir; 2017 Oct; 34(8):820-833. PubMed ID: 28506728
[TBL] [Abstract][Full Text] [Related]
37. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
38. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
[TBL] [Abstract][Full Text] [Related]
39. The excessive use of inhaled corticosteroids in chronic obstructive pulmonary disease.
Izquierdo Alonso JL; Rodríguez Glez-Moro JM
Arch Bronconeumol; 2012 Jun; 48(6):207-12. PubMed ID: 22385832
[TBL] [Abstract][Full Text] [Related]
40. The role of corticosteroids in chronic obstructive pulmonary disease.
Calverley PM
Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
